Induction of apoptosis in prostate cancer cells by the novel ceramidase inhibitor ceranib-2

In Vitro Cellular and Developmental Biology - Animal

Volumn 51, Issue 10, 2015, Pages 1056-1063

  Kus, Gokhan ^a   Kabadere, Selda ^b   Uyar, Ruhi ^b   Kutlu, Hatice Mehtap ^a  

^a ANADOLU UNIVERSITY   (Turkey)

^b ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Anticancer; Apoptotic; Ceramide; Ceranib 2; Prostate cancer

Indexed keywords

3-(3-(4-METHOXYPHENYL)ACRYLOYL)-4-PHENYL-1H-QUINOLIN-2-ONE; ANTINEOPLASTIC AGENT; CERAMIDASE; QUINOLONE DERIVATIVE;

ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL SURVIVAL; CONFOCAL MICROSCOPY; CYTOLOGY; DRUG EFFECTS; HUMAN; MALE; PATHOLOGY; PROSTATE; PROSTATIC NEOPLASMS; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; CERAMIDASES; HUMANS; MALE; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; PROSTATE; PROSTATIC NEOPLASMS; QUINOLONES;

EID: 84946409159     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-015-9932-9     Document Type: Article

References (24)

1. Beckham TH, Elojeimy S, Cheng JC, Turner LS, Hoffman SR, Norris JS, Liu X (2010) Targeting sphingolipid metabolism in head and neck cancer: rational therapeutic potentials. Expert Opin Ther Targets 14:529–39
2. Draper JM, Xia Z, Smith RA, Zhuang Y, Wang W, Smith CD (2011) Discovery and evaluation of inhibitors of human ceramidase. Mol Cancer Ther 10:2052–61
3. Engedal N, Saatcioglu F (2001) Ceramide-induced cell death in the prostate cancer cell line LNCaP has both necrotic and apoptotic features. Prostate 46:289–297
4. Gewies A, Rokhlin OW, Cohen MB (2000) Ceramide induces cell death in the human prostatic carcinoma cell lines PC3 and DU145 but does not seem to be involved in Fas-mediated apoptosis. Lab Invest 80:671–676
5. Holman DH, Turner LS, El-Zawahry A, Elojeimy S, Liu X, Bielawski J, Szulc ZM, Norris K, Zeidan YH, Hannun YA, Bielwska A, Norris JS (2008) Lysosomotric acid ceramidase inhibitor induces apoptosis in prostate cancer cells. Cancer Chemother Paharmacol 61:231–242
6. Huerta S, Gaulet EJ, Huerta-Yepez S, Livingston EH (2007) Screening and detection of apoptosis. J Surg Res 139:143–56
7. Kim YJ, Kim EA, Sohn UY, Yim CB, Im C (2010) Cytotoxic activity and structure activity relationship of ceramide analogues in Caki-2 and HL-60 cells. Korean J Physiol Pharmacol 14:441–447
8. Liu X, Cheng JC, Turner LS, Elojeimy S, Beckham TH, Bielawska A, Keane TE, Hannun YA, Norris JS (2009) Acid ceramidase up-regulation in prostate cancer: role in tumor development and implications for therapy. Expert Opin Ther Targets 13:1449–58
9. Mimeault M, Pommery N, Wattez N, Bailly C, Henichart JP (2003) Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implications of epidermal growth factor receptor down regulation and ceramide production. Prostate 56:1–12
10. Mossmann T (1983) Rapid colorimetric assay of cellular growth and survival: application to proliferation and cytotoxicity assay. J Immun Method 65:55–63
11. Norris JS, Bielawska A, Day T, El-Zawahry A, Elojeimy S, Hannun YA, Holman D, Hyer M, Landon C, Lowe S, Dong JY, Mckillop J, Norris K, Obeid L, Rubinchik S, Tavassoli M, Tomlinson S, Voelkel JS, Liu X (2006) Combined therapeutic use of AdGFPFasL and small molecule inhibitors of ceramide metabolism in prostate and head and neck cancers: a status report. Cancer Gene Ther 13:1045–51
12. Ogretmen B, Hannun YA (2004) Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer 4:604–16
13. Oskouian B, Saba J (2010) Cancer treatment strategies targeting sphingolipid metabolism. Adj Exp Med Biol 688:185–205
14. Proksch D, Klein JK, Arenz C (2011) Potent inhibition of acid ceramidase by novel B-13 analogues. J Lipids 20011:1–8
15. Ravindran J, Prasad S, Aggarwal BB (2009) Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J 11:595–610
16. Realini N, Solorzano C, Pagliuca C, Pizzirani D, Armirotti A, Luciani R, Costi MP, Bandiera T, Piomelli D (2013) Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity. Sci Rep 8:3. doi:10.1038/srep01035
17. Saad AF, Meacham WD, Bai A, Anelli V, Elojeimy S, Mahdy AE, Turner LS, Cheng J, Bielawska A, Bielawski J, Keane TE, Obeid LM, Hannun YA, Norris JS, Liu X (2007) The functional effects of acid ceramidase overexpression in prostate cancer progression and resistance to chemotherapy. Cancer Biol Ther 6:1455–60
18. Samsel L, Zaidel G, Drumgoole HM, Jelovac D, Drachenberg C, Rhee JG, Brodie AMH, Bielawska A, Smyth MJ (2004) The ceramide analog B13 induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts. Prostate 58:382–393
19. Samuel RD, John TI (2002) A history of prostate cancer treatment. Nat Rev Cancer 2:389–96
20. Seelan RS, Qian C, Yokomiza A, Bostwick DG, Smith DI, Liu W (2000) Human acid ceramidase is overexpressed but not mutated in prostate cancer. Genes Chromosomes Cancer 29:137–46
21. Selzner M, Bielawska A, Morse MA, Rudiger HA, Sindram D, Hannun YA, Clavie PA (2001) Induction of apoptotic cell death and prevention of tumor growth by ceramidase analogues in metastatic human colon cancer. Cancer Res 61:1233–40
22. Stiban J, Fistere D, Colombini M (2006) Dihydroceramide hinders ceramide channel formation: implications on apoptosis. Apoptosis 11:773–780
23. Strelow A, Bernardo K, Klages SA, Linke T, Sandhoff K, Kronke M (2000) Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death. J Exp Med 192:601–11
24. Vejselova D, Kutlu HM, Kuş G, Kabadere S, Uyar R (2014) Cytotoxic and apoptotic effects of ceranib-2 offering potential for a new antineoplastic agent in the treatment of cancer cells. Turk J Biol 38:916–921